최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기약학회지 = Yakhak hoeji, v.62 no.3, 2018년, pp.179 - 185
강원호 (충남대학교 약학대학) , 채정우 (충남대학교 약학대학) , 윤휘열 (충남대학교 약학대학)
To determine a rational preclinical formulation strategy for preclinical research, scientists should consider with their own work-flow and physicochemical properties acquired by each discovery stage. In general, physicochemical properties such as ionization states and kinetic solubility could be obt...
Suma, G., Amr, N. and Alan, G. W. : Development and application of a high-throughput formulation screening strategy for oral administration in drug discovery. Future Med. Chem. 2, 1391 (2010).
Roy, H., Allen, T., Stephen, B. and Thomas, E. P. : Discovering and Developing Molecules with Optimal Drug-Like Properties. Springer. New York(2015).
Margaret, S. L., Shobha, B., Mehran, Y. and John, M. : Commentary: Why Pharmaceutical Scientists in Early Drug Discovery Are Critical for Influencing the Design and Selection of Optimal Drug Candidates. AAPS PharmSciTech. 19, 1(2017).
Jianling, W. and Suzanne, S. : Recent advances in physicochemical and ADMET profiling in drug discovery. CHEMISTRY & BIODIVERSITY. 6, 1887(2009).
Christel, A. S. B. and Mehran, Y. : Lipophilicity in Drug Development: Too Much or Not enough?. The AAPS Journal. 18, 1095(2016).
Seshadri, N. : Preclinical formulations for discovery and toxicology: physicochemical challenges. Expert Opin. Drug Metab. Toxicol. 2, 715(2006).
Sanket, M. S., Ankitkumar, S. J., Ritu, K., Mangal, S. N. and Maneesh, J. N. : Preclinical Formulations: Insight, Strategies, and Practical Considerations. AAPS PharmSciTech. 15, 1307(2014).
Paul, D. L. and Brian, S. : The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Review Drug Discovery. 6, 881(2007).
Shayne, C. G., Nicolas, A., Bart, S., Heide, R. and Crystal, D. C. : Nonclinical vehicle use in studies by multiple routes in multiple species. International Journal of toxicology. 25, 499(2006).
Ashutosh, K., Jennifer, R., Cindy, P., April, B., Andrew, C., Tao, S. and Mehran, F. M. : Proposing advancement criteria for efficient DMPK triage of new chemical entities. Future Med. Chem. 6, 131(2014).
Mehran, F. M., Yang, T., Zhihong, O., Samantha, J. R., Maria, B., Prasoon, C., Julius, A. and Ashutosh, K. : A proposed screening paradigm for discovery of covalent inhibitor drugs. Drug Metabolism Letter. 8, 19(2014).
Edward, H. K., Li, D. : Drug-like properties: Concepts, Structure design and method, Elsevier Inc. San Diego(2008).
Siamak, C. K., Harvey, W. and Cornelis, E. C. A. H. : Drug metabolism and pharmacokinetics quick guide. Springer, New York(2011).
John, A. A. and Sonia, L. P. : The influence of lipophilicity in drug discovery and design. Expert Opin. Drug Discov. 7, 909(2012).
Patricia, V. T., Cynthia, P., Mary, A. V. and Thea, B. : Administration of substances to laboratory animals: Equipment considerations, vehicle selection, and solute preparation. Journal of the American for Laboratory Animal Science. 50, 614(2011).
Thorsteinn, L., Maria, D. M. O., Carmen, A. L. and Angel, C. : Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug/cyclodextrin complexes. Journal of Pharmacy And Pharmacology. 68, 544(2016).
Yung-Chi, L., Philip, D. Z. and Brian, S. : An intravenous formulation decision tree for discovery compound formulation development. International Journal of Pharmaceutics. 253, 111(2003).
Ping, L. and Luwei, Z. : Developing early formulations: Practice and perspective. International Journal of Pharmaceutics. 341, 1(2007).
Sandeep, K., Mohanvarma, M. and Veerabhadhraswamy, P. : Oral lipid-based drug delivery system - an overview. Acta Pharmaceutica Sinica B. 3, 361(2003).
Orlagh, M. F., Matthew, F. C., Claire, L. M., Natalie, L. T., Hywel, D. W., Colin, W. P., William, N. C., Christel, A. S. B. and Christopher, J. H. P. : 50 years oral lipid-based formulations: Provenance, progress and future perspectives. Advanced Drug Delivery Review. 101, 167(2016).
Abu, T. M. S., Salt formation to improve drug solubility. Advanced Drug Delivery Reviews. 59, 603(2007).
Michael, P., John, D. H., Elizabeth, K., and Allen, C. T. : Strategies at the Interface of Drug Discovery and Development: Early Optimization of the Solid State Phase and Preclinical Toxicology Formulation for Potential Drug Candidates. Journal of Medicinal Chemistry, 53, 5897(2010).
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.